TRACON Pharmaceuticals Inc (TCON)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4350 LA JOLLA VILLAGE DRIVE SAN DIEGO, CA 92122

TRACON Pharmaceuticals, Inc. is a clinical state biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related muscular degeneration, and fibrotic diseases. The Company uses endoglin biology to develop antibodies that bind to the endoglin receptor. TRACON operates in the United States.

Data as of 2021-05-08 11:38:53 -0400
Market Cap100.143 Million Shares Outstanding15.502 Million Avg 30-day Volume150.83 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.95 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.45279 52-week High/Low12.2 / 1.55 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TCON instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 1 (0.06%) 0 (0.0%)
Funds Holding: 39 27 44.44% 17 (1.02%) 10 (0.62%) 70.0%
13F shares: 8.485 Million 5.75 Million 47.58% 7.082 Million 5.075 Million 39.56%
% Ownership 58.4017 42.0153 39.0% 48.7432 37.0821 31.45%
New Positions: 15 13 15.38% 7 5 40.0%
Increased Positions 12 3 300.0% 5
Closed Positions 3 5 -40.0% 4
Reduced Positions 4 4 0.0% 2 3 -33.33%
Total Calls 9.605 Thousand
Total Puts 805
PUT/CALL Ratio 0.08
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TCON (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TCON BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BROWN SCOTT B. CHIEF FINANCIAL OFFICER

  • Officer
3,128 2021-03-08 2

JOHNSON-PRATT LISA

  • Director
0 2021-03-02 2

THEUER CHARLES PRESIDENT AND CEO

  • Officer
  • Director
0 2021-01-29 12

WIGGINS MARK C CHIEF BUSINESS OFFICER

  • Officer
0 2021-01-29 3

IKARIAN CAPITAL, LLC

IKARIAN HEALTHCARE MASTER FUND, L.P.

IKARIAN HEALTHCARE FUND GP, L.P.

CHART WESTCOTT LIVING TRUST

SHAHRESTANI NEIL

  • 10% Owner
  • MEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUP
2,716,840 2020-12-30 5

OPALEYE MANAGEMENT INC.

  • 10% Owner
2,518,371 2020-12-22 7

IKARIAN CAPITAL, LLC

IKARIAN HEALTHCARE MASTER FUND, L.P.

SHAHRESTANI NEIL

  • 10% Owner
  • MEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUP
2,162,549 2020-09-04 5

IKARIAN CAPITAL, LLC

  • 10% Owner
  • MEMBER OF 10% GROUP
1,840,078 2020-09-03 5

CHART WESTCOTT LIVING TRUST

IKARIAN HEALTHCARE MASTER FUND, L.P.

IKARIAN HEALTHCARE FUND GP, L.P.

SHAHRESTANI NEIL

  • 10% Owner
  • MEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUP
1,840,078 2020-09-03 1

LARUE WILLIAM R

  • Director
0 2020-06-10 1

MATTINGLY MARTIN A

  • Director
0 2020-06-10 1

TWIFORD J RAINER

  • Director
0 2020-06-10 1

WALKER PAUL EDWARD

  • Director
0 2020-06-10 1

WORLAND STEPHEN T

  • Director
0 2020-06-10 1

PELLETIER SAUNDRA L

  • Director
5,500 2020-06-10 1

PUISSANCE CROSS-BORDER OPPORTUNITIES V LLC

PUISSANCE CROSS-BORDER OPPORTUNITIES IV LLC

PUISSANCE CAPITAL MANAGEMENT LP

PUISSANCE CAPITAL FUND (GP) LLC

PUISSANCE CAPITAL MANAGEMENT (GP) LLC

WANG THEODORE T

  • 10% Owner
76,048 2019-12-05 0

PUISSANCE CROSS-BORDER OPPORTUNITIES V LLC

PUISSANCE CROSS-BORDER OPPORTUNITIES IV LLC

PUISSANCE LIFE SCIENCE OPPORTUNITIES FUND VI

PUISSANCE CAPITAL MANAGEMENT LP

PUISSANCE CAPITAL MANAGEMENT (GP) LLC

PUISSANCE CAPITAL FUND (GP) LLC

WANG THEODORE T

  • Director
  • 10% Owner
9,207,862 2018-11-29 0

WANG THEODORE T

  • Director
  • 10% Owner
0 2018-06-13 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

BARRIS PETER J

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

BARRETT M JAMES

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

MOTT DAVID M

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

KERINS PATRICK J

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

SANDELL SCOTT D

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

BASKETT FOREST

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

FLORENCE ANTHONY A. JR.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

SONSINI PETER W.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

VISWANATHAN RAVI

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
3,466,003 2018-03-27 0

BITAR PATRICIA L CFO

  • Officer
0 2018-02-21 0

LOGAN H CASEY CHIEF BUSINESS OFFICER

  • Officer
27,754 2018-01-22 0

SONSINI PETER W.

  • 10% Owner
2,758,039 2016-11-29 0

VISWANATHAN RAVI

  • 10% Owner
2,758,039 2016-11-29 0

KERINS PATRICK J

  • 10% Owner
2,758,039 2016-11-29 0

KOLLURI KRISHNA KITTU

  • 10% Owner
2,758,039 2016-11-29 0

MOTT DAVID M

  • 10% Owner
2,758,039 2016-11-29 0

SANDELL SCOTT D

  • 10% Owner
2,758,039 2016-11-29 0

BARRIS PETER J

  • 10% Owner
2,758,039 2016-11-29 0

BASKETT FOREST

  • 10% Owner
2,758,039 2016-11-29 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
2,758,039 2016-11-29 0

BARRETT M JAMES

  • 10% Owner
2,758,039 2016-11-29 0

SHAZER RONALD L CHIEF MEDICAL OFFICER

  • Officer
335 2016-06-03 0

JAFCO SUPER V3 INVESTMENT LIMITED PARTNERSHIP

  • 10% Owner
1,497,053 2015-10-16 0

BROOKLINE TRACON INVESTMENT FUND II, LLC

BROOKLINE TRACON INVESTMENT FUND LLC

CSA BIOTECHNOLOGY FUND I, LLC

CSA BIOTECHNOLOGY FUND II, LLC

  • 10% Owner
No longer subject to file 2015-07-30 0

WELLER HARRY R

  • 10% Owner
1,888,474 2015-02-04 0

DRANT RYAN D

  • 10% Owner
1,888,474 2015-02-04 0

HOZOJI HIRONORI

  • Director
0 2015-01-29 0

HARADA KENJI

  • Director
0 2015-01-29 0

BROOKLINE TRACON INVESTMENT FUND II, LLC

CSA BIOTECHNOLOGY FUND II, LLC

  • 10% Owner
580,050 2015-01-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TRACON PHARMACEUTICALS INC TCON 2021-05-10 22:15:04 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 21:45:02 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 21:15:02 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 20:45:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 20:15:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 19:45:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 19:15:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 18:45:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 18:15:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 17:45:02 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 17:15:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 16:45:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 16:15:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 15:45:03 UTC -0.621 0.671 90000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 15:15:03 UTC -0.621 0.671 95000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 14:45:04 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 14:15:04 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 13:45:04 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 13:15:03 UTC -0.621 0.671 100000
TRACON PHARMACEUTICALS INC TCON 2021-05-10 12:45:02 UTC -0.621 0.671 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments